BIOITHAS

Bioithas is a Spanish biotechnology and pharmaceutical company that develops clinically-formulated probiotic supplements, biomarkers, and diagnostic tools. Founded in 2017 and based in Alicante, the firm operates as a research center that studies the human microbiota and its connection to various pathologies. By leveraging scientific research and conducting clinical trials, Bioithas creates innovative probiotic blends designed for skin, digestive, and immune health. The company also serves as a contract research organization (CRO), offering scientific consulting and patent licensing services to other pharmaceutical and industrial partners.

The company's work is essential for customers and partners seeking scientifically-validated, probiotic-based adjuvant treatments for conditions such as atopic dermatitis, psoriasis, and acne. By adhering to the rigorous methodology of clinical trials, Bioithas ensures its products meet objective effectiveness standards. Through its focus on the human microbiome as a therapeutic target, the company bridges the gap between scientific investigation and consumer health, providing patent-backed products that complement natural biological processes. Their research efforts include exploring links between microbiota and diseases like multiple sclerosis and various cancers, establishing them as a key player in clinical-grade microbiome research.